Cardiovascular Recovery in Anthracycline Cardiotoxicity

Late Effects of Cancer Treatment: Managing Cardiac ToxicityПодробнее

Anthracycline CardiotoxicityПодробнее

Anthracycline Cardiotoxicity: The Role of Cardio-Oncology in ManagementПодробнее

Medication to prevent anthracycline cardiotoxicityПодробнее

Medicine Grand Rounds: "Cardio-Oncology: A New Frontier" 1/31/2023Подробнее

Mechanism-based Serum Peptidomic Study in Anthracycline Cardiotoxicity PreventionПодробнее

Beyond anthracyclines and trastuzumab: cardiotoxicity of novel agentsПодробнее

How does oncology drug induce cardiotoxicity? Overview: mechanism & clinical guidelines (ESMO) 2022Подробнее

Cardio-Oncology: What do we know beyond anthracycline cardiotoxicity? Dr. Lili ZhangПодробнее

Cardio-Oncology: What do we know beyond anthracycline cardiotoxicity, Dr. Lili ZhangПодробнее

CCC 2019: CANADIAN HEART FAILURE SOCIETY SPOTLIGHT: CARDIO-ONCOLOGYПодробнее

Medication to prevent anthracycline cardiotoxicity - IntroПодробнее

Cardio-Oncology: Cancer-Therapeutics Related Cardiac DysfunctionПодробнее

Cardiac Dysfunction in Breast Cancer Patients: Monitoring, Diagnosis, and TreatmentПодробнее

Anthracycline Cardiotoxicity: Clinical TypesПодробнее

DIAGNOSIS OF ANTHRACYCLINE RELATED CARDIOTOXICITY Dr Amel AMROUCHEПодробнее

“Past, Present and Future Ways to Detect Cardiotoxicity”Подробнее

Heart Minute | Detecting Cardiotoxicity During ChemoRxПодробнее

Cardio-oncology A-Z: Late Effects Cardiotoxicity | Dr Neha BansalПодробнее

JACC: CardioOncology Video Case Presentation: Cardiotoxicity During HER2-Targeted TherapyПодробнее